8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Mar 3, 2026·SEC
Material company update
Jan 20, 2026·SEC
908 Devices Inc.(MASS)Earnings, Financials & Key Ratios
MASS•NASDAQ
$8.07
14.9× P/E·Price updated Jul 7, 2026
About908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.Show more
- Revenue$56M-5.8%
- EBITDA-$20M+72.6%
- Net Income-$37M+49.3%
- EPS (Diluted)0.54+125.5%
- Gross Margin47.68%-5.0%
- EBITDA Margin-35.08%+71.0%
- Operating Margin-43.03%+66.6%
- Net Margin-65.2%+46.2%
- ROE-28.37%+45.0%
MASS Price & Volume
908 Devices Inc. (MASS) stock price & volume — 10-year historical chart
Loading chart...
Persistent Revenue Volatility Challenges Operational Scalability Outlook
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Healthy
Cash Flow:Burning
Primary Risk:Persistent operating cash burn
Key Thesis Takeaways
- 908 Devices faces a challenging path to profitability as it struggles to convert its specialized mass spectrometry technology into consistent operating income, evidenced by a -48.6% operating margin in 2026Q1.
- While the company maintains a robust liquidity buffer with a current ratio of 3.58, its reliance on lumpy government procurement cycles and high R&D spending creates significant earnings uncertainty.
- Investors should monitor the company's ability to stabilize gross margins, which have compressed from 53.8% in 2024Q2 to 47.7% in 2026Q1, before assuming a sustainable growth trajectory.
Verdict Logic
the company's inability to achieve consistent profitability, highlighted by a -48.6% operating margin in 2026Q1, suggests that the current cash burn rate poses a significant risk to long-term shareholder value.
MASS Growth Metrics
908 Devices Inc. (MASS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years15.88%
3 Years6.25%
TTM2.16%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-102.95%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-81.82%
Return on Capital
10 Years-23.83%
5 Years-22.46%
3 Years-28.86%
Last Year-16.66%
MASS Recent Earnings
908 Devices Inc. (MASS) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.22-46.7%
$0.15
Rev
$13M+1.7%
$13M
Q2 2026
Mar 3, 2026Metric
Actual
Est
EPS
$0.05+16.7%
$0.06
Rev
$17M+9.7%
$16M
Q4 2025
Nov 10, 2025Metric
Actual
Est
EPS
$0.15-30.4%
$0.12
Rev
$14M+3.6%
$14M
Q3 2025
Aug 5, 2025Metric
Actual
Est
EPS
$0.18-12.5%
$0.16
Rev
$13M-4.0%
$14M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.22vs $0.15-46.7% | $13Mvs $13M+1.7% |
| Q2 2026 | Mar 3, 2026 | $0.05vs $0.06+16.7% | $17Mvs $16M+9.7% |
| Q4 2025 | Nov 10, 2025 | $0.15vs $0.12-30.4% | $14Mvs $14M+3.6% |
| Q3 2025 | Aug 5, 2025 | $0.18vs $0.16-12.5% | $13Mvs $14M-4.0% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for 908 Devices Inc. (MASS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $8.07 | $305.16M | 14.94 | -5.76% | -65.2% | -28.37% | — | |
| $179.95 | $9.42B | -64.27 | -27.1% | 4.9% | 9.08% | — | |
| $374.93 | $24.44B | 34.84 | 6.99% | 11.91% | 8.04% | — | |
| $131.14 | $37.04B | 28.70 | 6.73% | 19.55% | 20.84% | — | |
| $516.62 | $191.99B | 29.12 | 3.91% | 15.18% | 13.23% | — | |
| $58.25 | $8.87B | -388.33 | 2.08% | -0.34% | -0.5% | — |
Compare MASS vs Peers
908 Devices Inc. (MASS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
MASS SEC Filings & Documents
908 Devices Inc. (MASS) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when MASS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
MASS Frequently Asked Questions
908 Devices Inc. (MASS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is 908 Devices Inc.'s revenue?
908 Devices Inc. (MASS) reported $57.8M in revenue for fiscal year 2025. This represents a 162% increase from $22.1M in 2018.
How fast is 908 Devices Inc. growing?
908 Devices Inc. (MASS) saw revenue decline by 5.8% over the past year.
Is MASS profitable?
908 Devices Inc. (MASS) reported a net loss of $35.9M for fiscal year 2025.
Dividend & Returns
What is MASS's return on equity?
908 Devices Inc. (MASS) has a return on equity (ROE) of -28.4%. Negative ROE indicates the company is unprofitable.
What is 908 Devices Inc.'s free cash flow?
908 Devices Inc. (MASS) had negative free cash flow of $8.4M in fiscal year 2025, likely due to heavy capital investments.